MR revealed that elevated levels of ARHGAP25 (OR = 1.45), HLA‐DRB1 (OR = 2.24), MERTK (OR = 1.10), MS4A6A (OR = 1.15), and SYK (OR = 1.13) increased MS risk. This evidence concerns the gene ARHGAP25 and myeloid sarcoma.